Physician profile
Thomas Finley
NPI 1396766713
$21,687.12
in general payments reported to CMS, 2019-2025
18 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,900 · 2020: $1,730 · 2021: $12K · 2022: $3,881 · 2023: $125 · 2024: $225 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $8,427.30 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $7,520.52 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $3,653.77 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Alcon Vision LLC | $385.27 | 2019-2022 | |
| Maculogix, INC. | $304.01 | 2019-2020 | |
| Coopervision INC. | $297.85 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $222.54 | 2019-2024 | |
| Allergan, INC. | $220.76 | 2019-2022 | |
| Sight Sciences, INC. | $143.77 | 2019-2024 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $122.92 | 2025 | |
| Glaukos Corporation | $104.08 | 2022 | |
| Visioneering Technologies, INC. | $76.51 | 2019 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Abbvie INC. | $64.39 | 2022 | |
| Oyster Point Pharma, INC. | $24.68 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $23.29 | 2020 | |
| Kala Pharmaceuticals, INC. | $18.50 | 2022 | |
| Oasis Medical, INC. | $11.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Finley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.